- Home
- HROW vs MCRI Comparison
HROW vs MCRI Comparison
Compare HROW & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- MCRI
- Stock Information
- Founded
- HROW 1998
- MCRI 1972
- Country
- HROW United States
- MCRI United States
- Employees
- HROW N/A
- MCRI N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- MCRI Hotels/Resorts
- Sector
- HROW Health Care
- MCRI Consumer Discretionary
- Exchange
- HROW Nasdaq
- MCRI Nasdaq
- Market Cap
- HROW 1.4B
- MCRI 1.6B
- IPO Year
- HROW N/A
- MCRI 1993
- Fundamental
- Price
- HROW $33.71
- MCRI $92.65
- Analyst Decision
- HROW Strong Buy
- MCRI Hold
- Analyst Count
- HROW 7
- MCRI 5
- Target Price
- HROW $68.50
- MCRI $97.60
- AVG Volume (30 Days)
- HROW 558.8K
- MCRI 104.0K
- Earning Date
- HROW 11-10-2025
- MCRI 10-21-2025
- Dividend Yield
- HROW N/A
- MCRI 1.29%
- EPS Growth
- HROW N/A
- MCRI N/A
- EPS
- HROW N/A
- MCRI 4.41
- Revenue
- HROW $227,661,000.00
- MCRI $539,635,000.00
- Revenue This Year
- HROW $43.92
- MCRI $6.99
- Revenue Next Year
- HROW $41.22
- MCRI $3.72
- P/E Ratio
- HROW N/A
- MCRI $21.01
- Revenue Growth
- HROW 47.69
- MCRI 4.61
- 52 Week Low
- HROW $20.85
- MCRI $69.99
- 52 Week High
- HROW $54.19
- MCRI $113.88
- Technical
- Relative Strength Index (RSI)
- HROW 31.53
- MCRI 44.40
- Support Level
- HROW $36.20
- MCRI $88.13
- Resistance Level
- HROW $38.52
- MCRI $92.24
- Average True Range (ATR)
- HROW 1.65
- MCRI 2.59
- MACD
- HROW -0.43
- MCRI 0.28
- Stochastic Oscillator
- HROW 10.74
- MCRI 47.66
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.